Enhabit Home Health & Hospice Announces Date of 2024 Fourth Quarter Earnings Call

Business Wire
14 Feb

DALLAS, February 13, 2025--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on March 5, 2025, and host a webcast and conference call on March 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

  • March 6, 2025
  • 10 a.m. EDT
  • Toll-free: 888-660-6150
  • International: 929-203-0843
  • Conference ID: 5248158
  • Internet website: https://events.q4inc.com/attendee/519715442

A link to the webcast of the conference call and online replay can be found on Enhabit’s investor website.

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 256 home health locations and 112 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250213908675/en/

Contacts

Investor relations contact
Jobie Williams
investorrelations@ehab.com
469-860-6061


Media contact
Erin Volbeda
media@ehab.com
972-338-5141


Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10